Coloplast expects organic growth of 7 percent next year
For the financial year 2021/2022, Coloplast is anticipating an organic growth of 7 percent in current exchange rates and an EBIT margin of 32 percent, it reports in connection with the release of its year-end results from the skewed 2020/21 financial year.
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY DANIEL PEDERSEN
Medtech company Coloplast is expecting to reach the same organic growth it landed on in the financial year that just ended for the next financial year of 2021/2022, it states in its year-end report from 2020/2021, which was released on Monday.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
